SCHEMBL13017683

SCHEMBL13017683

CC1C[C@@H](C)CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17517018 1.00
SCHEMBL10203797 1.00
SCHEMBL17517019 1.00
SCHEMBL13211870 1.00
SCHEMBL19122090 1.00
SCHEMBL19062931 1.00
SCHEMBL8061439 1.00
SCHEMBL18634424 1.00
SCHEMBL29332287 0.83
SCHEMBL11917825 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238281-A1 PIPERAZINE DERIVATIVES AND APPLICATION THEREOF GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY (CN) 2024-07-18 US disclosed
US-11718610-B2 Compounds containing benzosultam MEDSHINE DISCOVERY INC. (CN) 2023-08-08 US disclosed
US-20230183230-A1 COMPOUNDS CONTAINING BENZOSULTAM SUZHOU GENHOUSE BIO CO., LTD. (CN) 2023-06-15 US disclosed
EP-3592741-B1 NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS PFIZER (US) 2023-02-15 EP disclosed
US-11339177-B2 Heteroaryl compounds as inhibitors of necrosis, composition and method using the same ACCRO BIOSCIENCE (HK) LIMITED (HK) 2022-05-24 US disclosed
US-20210155635-A1 HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND METHOD USING THE SAME ACCRO BIOSCIENCE (HK) LIMITED (HK) 2021-05-27 US disclosed
EP-1934238-B1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2017-06-28 EP disclosed
EP-2258708-A1 Macrolide compounds endowed with antiinflammatory activity Zambon S.p.A. (IT) 2010-12-08 EP disclosed